Adaptive Biotechnologies President and COO Julie Rubinstein Sells $1.05M of Stock
Julie Rubinstein, President and COO, sold 35,228 shares of Adaptive Biotechnologies Corp at $28.93 to $31.22 a share (average $29.73) in 4 transactions, worth $1.05M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 377,802 (-2.9%).
Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky Sells $60K of Stock
Susan Bobulsky, Chief Commercial Officer, MRD, sold 1,875 shares of Adaptive Biotechnologies Corp at $32.00 a share, worth $60K in total on Nov 11, 2026. Shares held after the trade: 387,475 (-0.5%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $709K of Stock
Julie Rubinstein, President and COO, sold 23,762 shares of Adaptive Biotechnologies Corp at $28.87 to $30.58 a share (average $29.82) in 5 transactions, worth $709K in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 377,802 (-0.5%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $954K of Stock
Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.78 to $27.88 a share (average $26.78) in 7 transactions, worth $954K in total between Nov 4, 2026 and Nov 6, 2026. Shares held after the trade: 377,802 (-0.9%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $929K of Stock
Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.23 to $27.45 a share (average $26.06) in 5 transactions, worth $929K in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 377,802 (-3.0%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $992K of Stock
Julie Rubinstein, President and COO, sold 35,443 shares of Adaptive Biotechnologies Corp at $26.58 to $28.44 a share (average $28.00) in 4 transactions, worth $992K in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 377,802 (-3.0%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $897K of Stock
Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $24.38 to $26.30 a share (average $25.18) in 6 transactions, worth $897K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 377,802 (-0.9%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $877K of Stock
Julie Rubinstein, President and COO, sold 35,543 shares of Adaptive Biotechnologies Corp at $24.05 to $25.57 a share (average $24.66) in 4 transactions, worth $877K in total between Oct 19, 2026 and Oct 21, 2026. Shares held after the trade: 377,802 (-1.5%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $890K of Stock
Julie Rubinstein, President and COO, sold 35,343 shares of Adaptive Biotechnologies Corp at $24.21 to $25.82 a share (average $25.17) in 4 transactions, worth $890K in total between Oct 14, 2026 and Oct 16, 2026. Shares held after the trade: 378,102 (-3.0%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $920K of Stock
Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.35 to $26.41 a share (average $25.81) in 4 transactions, worth $920K in total between Oct 9, 2026 and Oct 13, 2026. Shares held after the trade: 377,802 (-3.0%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $948K of Stock
Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.66 to $30.53 a share (average $26.60) in 6 transactions, worth $948K in total between Oct 6, 2026 and Oct 8, 2026. Shares held after the trade: 377,802 (-3.0%).
Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky Sells $193K of Stock
Susan Bobulsky, Chief Commercial Officer, MRD, sold 6,444 shares of Adaptive Biotechnologies Corp at $30.00 a share, worth $193K in total on Oct 6, 2026. Shares held after the trade: 389,350 (-1.6%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $1.01M of Stock
Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $27.57 to $29.67 a share (average $28.46) in 5 transactions, worth $1.01M in total between Oct 1, 2026 and Oct 5, 2026. Shares held after the trade: 377,802 (-1.4%).
Adaptive Biotechnologies Chief People Officer Francis Lo Sells $758K of Stock
Francis Lo, Chief People Officer, sold 26,792 shares of Adaptive Biotechnologies Corp at $27.52 to $28.61 a share (average $28.28) in 2 transactions, worth $758K in total on Oct 1, 2026. Shares held after the trade: 220,867 (-7.8%).
Adaptive Biotechnologies Chief People Officer Francis Lo Sells $3.24M of Stock
Francis Lo, Chief People Officer, sold 115,406 shares of Adaptive Biotechnologies Corp at $28.02 to $28.57 a share (average $28.06) in 2 transactions, worth $3.24M in total on Sep 16, 2026. Shares held after the trade: 220,867 (-3.4%).